Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy

Breast

Volumn 24, Issue 3, 2015, Pages 290-293

  Azim, Hatem A ^a   Vingiani, Andrea ^b   Peccatori, Fedro ^b   Viale, Giuseppe ^b,c   Loi, Sherene ^d   Pruneri, Giancarlo ^b,c  

^a JULES BORDET INSTITUTE   (Belgium)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Biology; Breast cancer during pregnancy; Tumour infiltrating lymphocytes; Young

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME; BREAST TUMOR; CELLULAR IMMUNITY; CYTOLOGY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PREGNANCY COMPLICATION; YOUNG ADULT;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; YOUNG ADULT;

EID: 84931372511     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2015.01.009     Document Type: Article

References (15)

1. Loi S., Sirtaine N., Piette F., Salgado R., Viale G., Van Eenoo F., et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. JClin Oncol 2013, 31:860-867.
2. Denkert C., Loibl S., Noske A., Roller M., Muller B.M., Komor M., et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. JClin Oncol 2010, 28:105-113.
3. Loi S., Michiels S., Salgado R., Sirtaine N., Jose V., Fumagalli D., et al. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Ann Oncol 2014, 25:1544-1550.
4. Salgado R., Denkert C., Demaria S., Sirtaine N., Klauschen F., Pruneri G., et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol 2015 Feb, 26(2):259-271.
5. Peccatori F.A., Azim H.A., Orecchia R., Hoekstra H.J., Pavlidis N., Kesic V., et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013, 24(Suppl.6):vi160-vi170.
6. Azim H.A., Santoro L., Russell-Edu W., Pentheroudakis G., Pavlidis N., Peccatori F.A. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 2012, 38:834-842.
7. Veenstra van Nieuwenhoven A.L., Heineman M.J., Faas M.M. The immunology of successful pregnancy. Hum Reprod Update 2003, 9:347-357.
8. Azim H.A., Botteri E., Renne G., Dell'orto P., Rotmensz N., Gentilini O., et al. The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study. Acta Oncol Stockh Swed 2012, 51:653-661.
9. Goldhirsch A., Winer E.P., Coates A.S., Gelber R.D., Piccart-Gebhart M., Thurlimann B., et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013, 24:2206-2223.
10. de Visser K.E., Eichten A., Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006, 6:24-37.
11. Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
12. Azim H.A., Brohee S., Peccatori F.A., Desmedt C., Loi S., Lambrechts D., et al. Biology of breast cancer during pregnancy using genomic profiling. Endocr Relat Cancer 2014, 21:545-554.
13. Lyons T.R., O'Brien J., Borges V.F., Conklin M.W., Keely P.J., Eliceiri K.W., et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 2011, 17:1109-1115.
14. Azim H.A., Michiels S., Bedard P.L., Singhal S.K., Criscitiello C., Ignatiadis M., et al. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res 2012, 18:1341-1351.
15. Azim H.A., Partridge A. Biology of breast cancer in young women. Breast Cancer Res 2014, 16:427.